AVITA Medical, Inc. (RCEL): Price and Financial Metrics


AVITA Medical, Inc. (RCEL): $18.63

-0.30 (-1.58%)

POWR Rating

Component Grades

Growth

S

Value

I

Momentum

G

Stability

N

Sentiment

U

Quality

P

RCEL Stock Price Chart Interactive Chart >

Price chart for RCEL

RCEL Price/Volume Stats

Current price $18.63 52-week high $29.34
Prev. close $18.93 52-week low $16.52
Day low $18.35 Volume 436,600
Day high $18.95 Avg. volume 152,603
50-day MA $18.94 Dividend yield N/A
200-day MA $20.58 Market Cap 463.81M

AVITA Medical, Inc. (RCEL) Company Bio


AVITA Medical, Inc. operates as a medicine company. The Company focuses on the development and commercialization of therapies to address unmet medical needs in patients with burns, chronic wounds, and aesthetics indications. AVITA Medical serves customers worldwide.


RCEL Latest News Stream


Event/Time News Detail
Loading, please wait...

RCEL Latest Social Stream


Loading social stream, please wait...

View Full RCEL Social Stream

Latest RCEL News From Around the Web

Below are the latest news stories about AVITA Medical Inc that investors may wish to consider to help them evaluate RCEL as an investment opportunity.

AVITA Medical to Present at the 2021 Cantor Virtual Global Healthcare Conference

VALENCIA, Calif., and MELBOURNE, Australia, Sept. 13, 2021 (GLOBE NEWSWIRE) -- AVITA Medical, Inc. (NASDAQ: RCEL, ASX: AVH), a regenerative medicine company that is developing and commercializing a technology platform that enables point-of-care autologous skin restoration for multiple unmet needs, announced today that its management will present at the 2021 Cantor Virtual Global Healthcare Conference on Monday, September 27, 2021 at 4:00 p.m. Eastern Daylight Time / Tuesday, September 28, 2021 at 6:00 a.m. Australian Eastern Standard Time.

Intrado Digital Media | September 13, 2021

Why the Avita Medical (ASX:AVH) share price is outperforming today

Avita shares are on the climb today. The post Why the Avita Medical (ASX:AVH) share price is outperforming today appeared first on The Motley Fool Australia .

The Motley Fool Australia | September 1, 2021

AVITA Medical to Participate at the Lake Street 2021 BIG5 Conference

VALENCIA, Calif., and MELBOURNE, Australia, Aug. 31, 2021 (GLOBE NEWSWIRE) -- AVITA Medical, Inc. (NASDAQ: RCEL, ASX: AVH), a regenerative medicine company that is developing and commercializing a technology platform that enables point-of-care autologous skin restoration for multiple unmet needs, announced today that its management will participate at the Lake Street 2021 BIG5 Conference on Tuesday, September 14, 2021. Authorized for release by the Chief Financial Officer of AVITA Medical, Inc.

Yahoo | August 31, 2021

AVITA Medical (ASX:AVH) share price up 7% following FY21 earnings

Financial year 2021 saw some key improvements in AVITA''s finances. The post AVITA Medical (ASX:AVH) share price up 7% following FY21 earnings appeared first on The Motley Fool Australia .

The Motley Fool Australia | August 26, 2021

AVITA Medical Reports Fourth Quarter and Fiscal Year 2021 Financial Results

VALENCIA, Calif., Aug. 26, 2021 (GLOBE NEWSWIRE) -- AVITA Medical, Inc. (NASDAQ: RCEL, ASX:AVH) (Company), a regenerative medicine company that is developing and commercializing a technology platform that enables point-of-care autologous skin restoration for multiple unmet needs, today reported financial results for its fourth quarter of fiscal year 2021, ended June 30, 2021. Fourth Quarter of Fiscal Year 2021 Highlights Total net revenue increased 166% to $10.3 million compared to $3.9 million

Yahoo | August 26, 2021

Read More 'RCEL' Stories Here

RCEL Price Returns

1-mo 6.46%
3-mo -13.55%
6-mo -13.11%
1-year -35.06%
3-year 176.00%
5-year 161.47%
YTD 0.27%
2020 -59.16%
2019 712.50%
2018 4.67%
2017 -41.82%
2016 24.27%

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!


Page generated in 0.8662 seconds.